Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of Advate 3000 IU (1 vs 2 Vials) in Hemophilia A
NCT00916032Phase 4Completed
- Sponsor
- Takeda
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Jun 2009; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00916032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916032.